3 - Low dose daily tadalafil for the improvement of Lower Urinary Tract Symptoms (LUTS) in patients undergoing Thulium Vapo-Resection of the Prostate (ThuVARP): clinical and instrumental correlation.
Continence · 2026-06 · 17 · 102340
DOI: 10.1016/j.cont.2026.102340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Continence, 2026-06. Verfasst von Giuseppe Saitta und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Saitta, G., Paola, G. D., Ceresoli, A. S., Meazza, A. L., & Seveso, M. (2026). 3 - Low dose daily tadalafil for the improvement of Lower Urinary Tract Symptoms (LUTS) in patients undergoing Thulium Vapo-Resection of the Prostate (ThuVARP): clinical and instrumental correlation. Continence, 17, 102340. https://doi.org/10.1016/j.cont.2026.102340
Vancouver
Saitta G, Paola GD, Ceresoli AS, Meazza AL, Seveso M. 3 - Low dose daily tadalafil for the improvement of Lower Urinary Tract Symptoms (LUTS) in patients undergoing Thulium Vapo-Resection of the Prostate (ThuVARP): clinical and instrumental correlation. Continence. 2026;17:102340. doi:10.1016/j.cont.2026.102340
BibTeX
@article{Saitta2026,
author = {Saitta, Giuseppe and Paola, Giuseppe Di and Ceresoli, Andrea Simone and Meazza, Attilio Luigi and Seveso, Mauro},
title = {3 - Low dose daily tadalafil for the improvement of Lower Urinary Tract Symptoms (LUTS) in patients undergoing Thulium Vapo-Resection of the Prostate (ThuVARP): clinical and instrumental correlation},
journal = {Continence},
year = {2026},
volume = {17},
pages = {102340},
doi = {10.1016/j.cont.2026.102340}
}
EUVIMED